Deutsche Bank
DRUG icon

Deutsche Bank’s Bright Minds Biosciences DRUG Stock Holding History

Deutsche Bank’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$347K Sell
6,973
-835
-11% -$58.9K ﹤0.01% 2809
2026
Q2 		$548K Buy
7,808
+1,550
+25% +$122K ﹤0.01% 2721
2026
Q1 		$457K Buy
6,258
+1,999
+47% +$161K ﹤0.01% 2616
2025
Q4 		$332K Buy
4,259
+3,640
+588% +$243K ﹤0.01% 2777
2025
Q3 		$37.5K Sell
619
-4,867
-89% -$189K ﹤0.01% 3460
2025
Q2 		$143K Buy
+5,486
New +$164K ﹤0.01% 3112

Other funds holding DRUG

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Deutsche Bank's DRUG Position: Q3 2026 in Review

Deutsche Bank reduced its Bright Minds Biosciences (DRUG) stake by 11% in Q3 2026, selling an estimated $58.9K and leaving 6,973 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Deutsche Bank first reported a position in DRUG in Q2 2025 and has held it in 6 quarters since. The position peaked at $548K in Q2 2026. 30 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

  • Deutsche Bank held 6,973 shares of Bright Minds Biosciences worth $347K as of Q3 2026.
  • Deutsche Bank sold 835 Bright Minds Biosciences shares in Q3 2026, an estimated $58.9K.
  • Bright Minds Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2809 holding.
  • Deutsche Bank first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 6 quarters since.
  • Deutsche Bank's Bright Minds Biosciences position peaked at $548K in Q2 2026.
  • 30 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.